Type your tag names separated by a space and hit enter

Allopurinol for chronic prostatitis

Evidence Summaries

Level of Evidence = D

Allopurinol might possibly relieve symptoms in patients with chronic prostatitis, but the evidence is insufficient.The level of evidence is downgraded because of study limitations (several issues) and imprecise results (very few patients).

A Cochrane review 1 included 1 study with a total of 54 men. Only one trial lasting 240 days (with 330 days of follow up) met study inclusion criteria. There was a statistically significant change favoring allopurinol in patient-reported discomfort between the study and control groups at follow up. Between days 45 to 225, the mean score was -0.95 (SD 0.19) for the allopurinol group (seven men), compared with -0.47 (SD 0.21) for the placebo group (seven men). The weighted mean difference (WMD) was -0.48 (95% CI -0.690 to -0.270). The mean score between days 45-135 was -1.08 (SD 1.29) for the 25 men in the allopurinol group, compared with -0.21 (SD 0.97) for the 14 men in the control group. The WMD was -0.87 (95% CI -1.587 to -0.153). The allopurinol group had significantly less investigator graded prostate pain and had lower levels of serum urate, urine urate, and expressed prostatic secretion urate and xanthine.

Date of latest search: 2002-08-01


1. McNaughton CO, Wilt T. Allopurinol for chronic prostatitis. Cochrane Database Syst Rev 2002;(4):CD001041.  [PMID:12519549]

Copyright © 2017 Duodecim Medical Publications Limited.
Allopurinol for chronic prostatitis is a sample topic from the Evidence-Based Medicine Guidelines.

To view other topics, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Learn more.


"Allopurinol for Chronic Prostatitis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457682/all/Allopurinol_for_chronic_prostatitis.
Allopurinol for chronic prostatitis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457682/all/Allopurinol_for_chronic_prostatitis. Accessed March 24, 2019.
Allopurinol for chronic prostatitis. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/457682/all/Allopurinol_for_chronic_prostatitis
Allopurinol for Chronic Prostatitis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457682/all/Allopurinol_for_chronic_prostatitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Allopurinol for chronic prostatitis ID - 457682 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457682/all/Allopurinol_for_chronic_prostatitis PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -